| Issue Date |
Title |
Author(s) |
| 2019 |
ALBUMIN AND PLATELET AFTER SIX MONTHS OF ANTIVIRAL THERAPY ARE INDEPENDENT SERUM MARKERS TO PREDICT LIVER RELATED EVENTS IN HBV-RELATED COMPENSATED LIVER CIRRHOSIS |
Wu, Xiaoning;Zhou, Jialing;Meng, Tongtong;Sun, Yameng;Wang, Bingqiong;Piao, Hongxin;Ding, Huiguo;Xu, Xiaoyuan;Jiang, Wei;Chen, Yongpeng;Xie, Wen;Ma, Anlin;Cheng, Jun, Sr.;Cheng, Jilin;Zhang, Mingxiang;Guan, Qiushuang;Chen, Shuyan;Shi, Yiwen;Duan, Weijia;Kong, Yuanyuan;Ou, Xiaojuan;You, Hong;Jia, Jidong |
| Nov-2020 |
ANTIVIRAL THERAPY IMPROVES LONG-TERM HEALTH RELATED QUALITY OF LIFE IN COMPENSATED HBV-CIRRHOSIS PATIENTS |
Wu, Xiaoning;Hong, Jia;Zhou, Jialing;Sun, Yameng;Ding, Huiguo;Xie, Wen;Piao, Hongxin;Xu, Xiaoyuan;Jiang, Wei;Feng, Bo;Xu, Mingyi;Cheng, Jilin;Ou, Xiaojuan;Jia, Jidong;You, Hong |
| 2018 |
Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B |
Shan, Shan;You, Hong;Niu, Junqi;Shang, Jia;Zhang, Yuexin;Ren, Hong;Tang, Hong;Ding, Huiguo;Zhang, Lingyi;Nan, Yuemin;Han, Tao;Wang, Xiaozhong;Liu, Xiaoqing;Dou, Xiaoguang;Xu, Xiaoyuan;Wei, Lai;Hou, Jinlin;Duan, Zhongping;Zhuang, Hui;Kong, Yuanyuan;Jia, Jidong |
| 2018 |
Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B |
Shan, Shan;You, Hong;Niu, Junqi;Shang, Jia;Zhang, Yuexin;Ren, Hong;Tang, Hong;Ding, Huiguo;Zhang, Lingyi;Nan, Yuemin;Han, Tao;Wang, Xiaozhong;Liu, Xiaoqing;Dou, Xiaoguang;Xu, Xiaoyuan;Wei, Lai;Hou, Jinlin;Duan, Zhongping;Zhuang, Hui;Kong, Yuanyuan;Jia, Jidong |
| Mar-2020 |
China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B |
Shan, Shan;Wei, Wei;Kong, Yuanyuan;Niu, Junqi;Shang, Jia;Xie, Wen;Zhang, Yuexin;Ren, Hong;Tang, Hong;Ding, Huiguo;Nan, Yuemin;Dou, Xiaoguang;Han, Tao;Xu, Xiaoyuan;Duan, Zhongping;Wei, Lai;Hou, Jinlin;Zhuang, Hui;You, Hong;Jia, Jidong |
| 2019 |
Chinese guidelines on the management of ascites and its related complications in cirrhosis |
Xu, Xiaoyuan;Duan, Zhongping;Ding, Huiguo;Li, Wengang;Jia, Jidong;Wei, Lai;Linghu, Enqiang;Zhuang, Hui |
| 2019 |
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir |
Kong, Yuanyuan;Sun, Yameng;Zhou, Dialing;Wu, Xiaoning;Chen, Yongpeng;Piao, Hongxin;Lu, Lungen;Ding, Huiguo;Nan, Yuemin;Jiang, Wei;Xu, Youqing;Xie, Wen;Li, Hanwei;Feng, Bo;Shi, Guangfeng;Chen, Guofeng;Li, Hai;Zheng, Huanwei;Cheng, Jilin;Wang, Tailing;Liu, Hui;Lv, Fudong;Shao, Chen;Mao, Yimin;Sun, Jihong;Chen, Tao;Han, Tao;Han, Ying;Wan, Lin;Ou, Xiaojuan;Zhang, Hui;Jia, Jidong;You, Hong |
| 2019 |
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study |
Wu, Xiaoning;Zhou, Jialing;Xie, Wen;Ding, Huiguo;Ou, Xiaojuan;Chen, Guofeng;Ma, Anlin;Xu, Xiaoyuan;Ma, Hui;Xu, Youqing;Liu, Xiaoqing;Meng, Tongtong;Wang, Lin;Sun, Yameng;Wang, Bingqiong;Kong, Yuanyuan;Ma, Hong;You, Hong;Jia, Jidong |
| 2016 |
Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B |
You, Hong;Kong, Yuanyuan;Hou, Jinlin;Wei, Lai;Zhang, Yuexin;Niu, Junqi;Han, Tao;Ou, Xiaojuan;Dou, Xiaoguang;Shang, Jia;Tang, Hong;Xie, Qing;Ding, Huiguo;Ren, Hong;Xu, Xiaoyuan;Xie, Wen;Liu, Xiaoqing;Xu, Youqing;Li, Yujie;Li, Jie;Chow, Shein-Chung;Zhuang, Hui;Jia, Jidong |
| 2016 |
HBsAg and HBeAg in the prediction of a clinical response to peginterferon alpha-2b therapy in Chinese HBeAg-positive patients |
Yang, Song;Xing, Huichun;Wang, Yuming;Hou, Jinlin;Luo, Duande;Xie, Qing;Ning, Qin;Ren, Hong;Ding, Huiguo;Sheng, Jifang;Wei, Lai;Chen, Shijun;Fan, Xiaoling;Huang, Wenxiang;Pan, Chen;Gao, Zhiliang;Zhang, Jiming;Zhou, Boping;Chen, Guofeng;Wan, Mobin;Tang, Hong;Wang, Guiqiang;Yang, Yuxiu;Xu, Dongping;Dong, Peiling;Wang, Qixin;Wang, Jue;Bognar, Fernando A.;Xu, Daozhen;Cheng, Jun |
| 2008 |
Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors |
Peng, Dandan;Han, Ying;Ding, Huiguo;Wei, Lai |
| 2017 |
New Classification of Liver Biopsy Assessment for Fibrosis in Chronic Hepatitis B Patients Before and After Treatment |
Sun, Yameng;Zhou, Jialing;Wang, Lin;Wu, Xiaoning;Chen, Yongpeng;Piao, Hongxin;Lu, Lungen;Jiang, Wei;Xu, Youqing;Feng, Bo;Nan, Yuemin;Xie, Wen;Chen, Guofeng;Zheng, Huanwei;Li, Hai;Ding, Huiguo;Liu, Hui;Lv, Fudong;Shao, Chen;Wang, Tailing;Ou, Xiaojuan;Wang, Bingqiong;Chen, Shuyan;Wee, Aileen;Theise, Neil D.;You, Hong;Jia, Jidong |
| 2019 |
On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon alpha add-on therapy |
Liu, Tianhui;Sun, Yameng;Zhou, Jialing;Yang, Fang;Zou, Xia;Wang, Lin;Wu, Xiaoning;Chen, Yongpeng;Piao, Hongxin;Lu, Lungen;Jiang, Wei;Xu, Youqing;Feng, Bo;Nan, Yuemin;Xie, Wen;Chen, Guofeng;Zheng, Huanwei;Li, Hai;Ding, Huiguo;Liu, Hui;Wang, Tailing;Ou, Xiaojuan;Wu, Shanshan;Kong, Yuanyuan;Wang, Ping;Cong, Min;Zhang, Yan;You, Hong;Jia, Jidong |
| 2014 |
Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial |
Cheng, Jun;Wang, Yuming;Hou, Jinlin;Luo, Duande;Xie, Qing;Ning, Qin;Ren, Hong;Ding, Huiguo;Sheng, Jifang;Wei, Lai;Chen, Shijun;Fan, Xiaoling;Huang, Wenxiang;Pan, Chen;Gao, Zhiliang;Zhang, Jiming;Zhou, Boping;Chen, Guofeng;Wan, Mobin;Tang, Hong;Wang, Guiqiang;Yang, Yuxiu;Mohamed, Rosmawati;Guan, Richard;Lee, Tzong-Hsi;Chang, Wen-Hsiung;Huang Zhenfei;Ye, Zhang;Xu, Daozhen |
| Oct-2022 |
Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus beta-blocker |
Chen, Yan;Ma, Xuemei;Zhang, Xuefeng;Luo, Jing;An, Linjing;Zhang, Yu;Chang, Xiujuan;Dong, Zheng;Zhang, Wei;Kong, Huifang;Zhao, Jun;Ding, Huiguo;Liu, Fuquan;Yang, Yongping |
| 2019 |
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China |
Sun, Jian;Ding, Huiguo;Chen, Guofeng;Wang, Guiqiang;Wei, Lai;Zhang, Jiming;Xie, Qing;Wan, Mobin;Tang, Hong;Chen, Shijun;Gao, Zhiliang;Wang, Yuming;Zhang, Dazhi;Huang, Wenxiang;Sheng, Jifang;Ning, Qin;Yang, Dongliang;Lu, Jian;Pan, Chen;Yang, Yuxiu;Wang, Jue;Sun, Chuanzhen;Wang, Qixin;Hou, Jinlin |
